Riken Vitamin Co Ltd
TSE:4526
Intrinsic Value
Riken Vitamin Co., Ltd. engages in the production and sale of consumer and commercial foods, processed food ingredients, food and chemical improvers, and vitamins. [ Read More ]
The intrinsic value of one
Riken Vitamin Co Ltd
stock under the Base Case scenario is
5 539.53
JPY.
Compared to the current market price of 2 753 JPY,
Riken Vitamin Co Ltd
is
Undervalued by 50%.
Riken Vitamin Co Ltd could be a value trap.A value trap occurs when a stock looks inexpensive based on fundamental analysis but fails to reach its intrinsic valuation over time, often due to underlying issues not reflected in quantitative data.
Scrutinize beyond numbers; assess long-term potential.
Riken Vitamin Co Ltd's market capitalization is 71B JPY.
Riken Vitamin Co Ltd stock price is 2 753 JPY.
Riken Vitamin Co Ltd stock price (2753 JPY) is 50% less than its Intrinsic Value (5 539.53 JPY).
Riken Vitamin Co Ltd stock price (2753 JPY) is 68% less than its DCF Value (8 582.36 JPY). Open DCF Valuation
Riken Vitamin Co Ltd stock (2 496.71 JPY) is 9% less than its price (2753 JPY). Open Relative Valuation
Riken Vitamin Co Ltd has upside potential of 56% compared to the average analyst price target.
Open Wall St Estimates
Riken Vitamin Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 10%.
Riken Vitamin Co Ltd has positive Net Income for the last twelve months.
Riken Vitamin Co Ltd's Revenue has grown by 4% over the past 12 months.
Riken Vitamin Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 8%.
Riken Vitamin Co Ltd's Revenue is forecast to grow at a rate of 5% per year over the next 3 years.
Riken Vitamin Co Ltd's Revenue has been growing by 5% per year for the last 3 years.
Riken Vitamin Co Ltd has positive Operating Income for the last twelve months.
Riken Vitamin Co Ltd has positive three-year average ROE (Return on Equity): 15%. The company is efficient at transforming stockholders' equity into net income.
Riken Vitamin Co Ltd has positive Free Cash Flow for the last twelve months.
Riken Vitamin Co Ltd's ROE (Return on Equity) has significantly increased in the last 3 years from -4% to 10%.
Riken Vitamin Co Ltd has positive Gross Profit for the last twelve months.
Riken Vitamin Co Ltd's Altman Z-Score is equal to 2.96.
Riken Vitamin Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 391% to 8%.
Riken Vitamin Co Ltd's short-term assets (65B JPY) exceed its short-term liabilties (25B JPY).
Riken Vitamin Co Ltd has very high three-year average ROIC (Return on Invested Capital): 36%. The company is very efficient at using invested capital to generate operating income.
Riken Vitamin Co Ltd's long-term assets (115B JPY) exceed its long-term liabilties (36B JPY).
Riken Vitamin Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.07.
Riken Vitamin Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (20B JPY) than debt (5B JPY).
Riken Vitamin Co Ltd earns more than enough operating income (9B JPY) to safely cover interest payments on its debt (118m JPY).
Valuation Backtest
Riken Vitamin Co Ltd
Run backtest to discover the historical profit from buying and selling
Riken Vitamin Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Riken Vitamin Co Ltd
Balance Sheet Decomposition
Riken Vitamin Co Ltd
| Current Assets | 64.7B |
| Cash & Short-Term Investments | 20.2B |
| Receivables | 24.8B |
| Other Current Assets | 19.7B |
| Non-Current Assets | 50.5B |
| Long-Term Investments | 21.4B |
| PP&E | 23.1B |
| Intangibles | 672m |
| Other Non-Current Assets | 5.2B |
| Current Liabilities | 24.9B |
| Accounts Payable | 10B |
| Other Current Liabilities | 14.9B |
| Non-Current Liabilities | 11.3B |
| Long-Term Debt | 5.3B |
| Other Non-Current Liabilities | 5.9B |
Earnings Waterfall
Riken Vitamin Co Ltd
|
Revenue
|
90.5B
JPY
|
|
Cost of Revenue
|
-61.7B
JPY
|
|
Gross Profit
|
28.8B
JPY
|
|
Operating Expenses
|
-20B
JPY
|
|
Operating Income
|
8.9B
JPY
|
|
Other Expenses
|
-1.2B
JPY
|
|
Net Income
|
7.6B
JPY
|
Free Cash Flow Analysis
Riken Vitamin Co Ltd
Profitability Score
Profitability Due Diligence
Riken Vitamin Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Score
Riken Vitamin Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Riken Vitamin Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Score
Riken Vitamin Co Ltd's solvency score is 85/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Riken Vitamin Co Ltd
According to Wall Street analysts, the average 1-year price target for
Riken Vitamin Co Ltd
is 4 300 JPY
.
Shareholder Return
Price
Riken Vitamin Co Ltd
| Average Annual Return | 6.42% |
| Standard Deviation of Annual Returns | 25.16% |
| Max Drawdown | -44% |
| Market Capitalization | 71B JPY |
| Shares Outstanding | 25 803 500 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Riken Vitamin Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Riken Vitamin Co., Ltd. engages in the production and sale of consumer and commercial foods, processed food ingredients, food and chemical improvers, and vitamins. The company is headquartered in Shinjuku, Tokyo-To and currently employs 2,248 full-time employees. The firm operates its business through three segments. The Domestic Food segment is primarily engaged in the manufacture and sale of household food products, commercial food products and raw materials for food processing, including seaweed products, dressings, food extracts and seasonings, food improving agents, vitamin and health food. The Domestic Chemicals and Others segment is mainly engaged in the manufacture and sale of chemical improving agents and animal feed additives. The Overseas segment is mainly engaged in the manufacture and sale of improving agents for food and chemical products, as well as processed marine products and frozen vegetables. The firm distributes its products in Japan, Southeast Asia, South Asia, the Middle East, Oceania, Europe, Africa, the North America, Latin America, China, Taiwan and South Korea, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Riken Vitamin Co Ltd
stock under the Base Case scenario is
5 539.53
JPY.
Compared to the current market price of 2 753 JPY,
Riken Vitamin Co Ltd
is
Undervalued by 50%.
You don't have any saved screeners yet
